Merck | MRK - Operating Profit



Merck reported EUR1.03B in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Adidas EUR 547M 63M Jun/2025
Adyen EUR 513.96M 321.12M Dec/2024
Akzo Nobel EUR 303M 111M Jun/2025
Alcon AG USD 247M 221M Jun/2025
Amadeus IT EUR 494.2M 32.4M Jun/2025
Amarin USD -16755000 35.77M Mar/2025
AstraZeneca USD 3.51B 166M Jun/2025
BASF EUR 827M 370M Jun/2025
Bayer EUR 13M 2.31B Jun/2025
Beiersdorf EUR 816M 370M Jun/2025
Covestro EUR 49M 146M Jun/2025
Danone EUR 1.81B 249M Jun/2025
Fresenius EUR 560M 127M Jun/2025
Fresenius Medical Care EUR 431M 100M Jun/2025
Galapagos EUR -57027000 101.68M Jun/2025
Genmab DKK 360M 172M Jun/2025
Givaudan CHF 364.5M 165.5M Jun/2024
GlaxoSmithKline GBP 2.02B 193M Jun/2025
GRIFOLS EUR 349.54M 80.68M Jun/2025
Henkel EUR 1.61B 249M Jun/2025
Hikma Pharmaceutical USD 282M 45M Dec/2024
Infineon EUR 531M 212M Jun/2025
Linde USD 2.34B 69M Jun/2025
Lonza CHF 430M 104M Dec/2024
Merck EUR 1.03B 24M Jun/2025
Novartis USD 4.86B 201M Jun/2025
Philips EUR 488M 334M Jun/2025
Roche Holding CHF 4.39B 1.04B Dec/2024
Sanofi EUR 1.71B 573M Jun/2025
UCB EUR 1B 678M Dec/2024